10h
Biocon Q3 net profit zooms 475% to Rs 144 crore as generics, biosimilars lift operating performance
Biocon Ltd.’s December quarter net profit rose 475 percent to Rs.144 crore in Q3FY26 from Rs.25 crore a year earlier, primarily by lower exceptional losses, compared with the prior year, alongside ...
Analysts advise investors to clearly distinguish between short-term trading and long-term investing in metals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results